The LiberHetica and BERC-Luso consortia will meet on the 26th March 2021 to discuss about Biomedical Ethics and Regulatory Capacity Building in Sub-Saharan African countries.

The LiberHetica and BERC-Luso are two projects funded by the European & Developing Countries Clinical Trials Partnership (EDCTP) aimed at strenghting ethics and regulatory capacities for clinical trials by partnerships between African and European countries, and involving 5 Sub-Saharan African countries (Liberia, Angola, Guinea Bissau, Mozambique and Cape-Verde) and 2 European countries (U.K. and Portugal).

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

OPTIMAL-RSV AFRICA PROPOSAL SUBMITTED TO EDCTP3 TO IMPROVING NEWBORN PROTECTION AGAINTS RESPIRATORY INFECTION IN AFRICA

Respiratory infections remain one of the main causes of illness and death among newborns in sub-Saharan Africa. Respiratory Syncytial Virus (RSV) is a major contributor to severe disease in the

PRECISION-asympTB – Proposal submitted to EDCTP3 call for innovative TB treatment research in sub-Saharan Africa

PRECISION-asympTB was submitted under the EDCTP3 2026 Call on Tuberculosis.  Despite decades of global efforts, TB remains one of the leading infectious causes of death worldwide. One of the greatest challenges today

INTEGRATION Annual Project Meeting Y2-Rome

The INTEGRATION consortium held its annual meeting of the year 2 of the project on 6th and 7th March 2023 in Rome, Italy. During the meeting, the progress of the